Life sciences procurement consulting · procurement transformation in pharma and animal health
For pharma, medtech and animal-health organizations where procurement, S2P/P2P, shared services and ERP governance carry regulatory weight. KULIC Advisory names where execution breaks, before the next system, program or committee gets funded.
02LIFE SCIENCES · PHARMA · MEDTECH · ANIMAL HEALTH
Four situations where regulated execution breaks.
Where procurement, S2P/P2P, shared services and ERP governance carry regulatory weight. Each file names the situation, the risk and the intervention. Below them, just as plainly: what this practice will not sell you.
4 SITUATIONS ON FILE · 9 THINGS OUT OF SCOPE · 6 IN SCOPE
01FILE 01STAGE · DIAGNOSE
S2P transformation under regulated pressure.
PRESSURE 4/5COMPOUNDING
DOMAIN
S2P
CONNECTORS ENGAGED
OWNERSHIP · GOVERNANCE · PROCESS
SITUATION
The program is live but drifting; Monday looks the same.
RISK
Supplier friction and cost leakage compound while audit exposure grows.
INTERVENTION
Execution diagnosis of ownership, decision rights and handoffs across the procurement–finance–quality interfaces.
WHAT THIS IS
A system diagnosis, not a validation or compliance service.
02FILE 02STAGE · FIX
ERP / S/4HANA decision rights.
PRESSURE 5/5IRREVERSIBLE
DOMAIN
ERP · S/4HANA
CONNECTORS ENGAGED
OWNERSHIP · TECHNOLOGY · GOVERNANCE
SITUATION
Master data, outline agreements and release strategies have no clear owner.
RISK
The go-live hardens broken governance into the system, and the window does not reopen.
INTERVENTION
A System Review of ownership and controls before the architecture question hardens.
WHAT THIS IS
Decision support, not implementation or certification.
The shared-service layer compensates for weak upstream ownership.
RISK
Cost and control erode quietly, invoice by invoice.
INTERVENTION
P2P operating-model review with documented value logic: USD 1M+ reported P2P cost reduction and USD 450K reported cost avoidance sit in the proof library.
Nine things that get quoted as if they were the same work. They are not.
This work covers regulated procurement, S2P/P2P, GBS and ERP governance. Everything below sits outside it, and where an engagement needs it, KULIC competes through partnerships, not pretense.
THE KULIC OPERATING SYSTEMONE SYSTEM · FOUR FIELDS · FIVE LAYERS
PHASE 01
DIAGNOSE
Name the break.
PHASE 02
FIX
Design the move.
PHASE 03
RUN
Take the field.
APPLIED TO
S2P
P2P
GBS
ERP · S/4HANA
PROCESS
OWNERSHIP
GOVERNANCE
TECHNOLOGY
LEADERSHIP RHYTHM
Execution Architecture™ and Human-Centered Execution™ connect process, ownership, governance, technology and leadership rhythm into one operating system.
SIGNAL OVER NOISE. SYSTEM OVER EGO.
Engagement file
Four named environments. One record.
PERSONALLY DELIVERED · DOCUMENTED FROM THE ENGAGEMENT FILE
05Elanco · Animal HealthTHREE YEARS · 40+ COUNTRIES
06Bayer AG · Pharma sourcingLEVERKUSEN · 2019
07GSK Vaccines · Pharma procurementBELGIUM · 2015 · REFERENCE CASE
08Merck Group · S2P architectureDARMSTADT · 2025–2026
09What was delivered, what is potentialSTATED EXACTLY
10The fileCONTEXT AND CONFIDENTIALITY
05 · ELANCO · GLOBAL PROCESS OWNER & DIRECTOR P2PPROCUREMENT PMO
Animal Health, lived end to end.
Three years at Elanco as Global Process Owner & Director P2P and Procurement PMO:
4,000+ EMPLOYEES40+ COUNTRIES130 POWER USERS
▸Stabilization lead for the carved-out Bayer Animal Health business: shared services, accounts payable, P2P, supplier master data, controls and governance.
▸Transformation change agent for 4,000+ employees across 40+ countries.
▸P2P organisation from 30 to 17 experts, carried by a global power-user model: 130 power users and 35 captains in 35 countries, rolled out in three months.
▸Owner of 12 P2P SoX controls; data domain owner for SAP purchasing contracts.
▸Top Performance Awards 2020 and 2021; Voice-of-the-Employee score Q3/22 around 25% above company average on participation and engagement.
06 · BAYER AG · LEVERKUSEN · 2019PROJECT PROCUREMENT LEAD
Pharma sourcing with a named outcome.
EUR 1,000,000 SAVINGSCAREER OUTCOME
▸Project procurement lead for strategic sourcing and project management of laboratory-scale devices in the pharma division.
▸EUR 1,000,000 savings, a career outcome from a named environment, personally delivered and documented from the engagement file.
▸Senior consultant for indirect procurement across CAPEX, OPEX, facility, maintenance, services and spare parts, with direct links to the Novartis integration.
▸Interim mandate as global sourcing category manager for secondary process equipment.
▸Mission evaluated by the client's director of indirect procurement; award for the best procurement consulting performance on the engagement.
▸Award for best project management in real-estate and facility projects; advisor to the purchasing director on Novartis acquisition synergies.
03Potential: modeled, not realized. Around 4M USD modeled AICTIONBOT™ value potential.
04Effort signal: supports the business case model.
10 · THE FILEPUBLICLY VERIFIABLE
A documented career.
These are employment and engagement contexts from a documented, publicly verifiable life-sciences career. Published proof cases stay deliberately industry-neutral; ongoing client relationships stay confidential. Every case is personally delivered and documented from the engagement file.
Work artifact
The source-to-pay metro map.
END-TO-END S2P · FROM PRACTICE
Not a stock graphic. A real work artifact from practice: the end-to-end S2P process landscape drawn as a transit map, so executives and process owners can argue over the same picture.
SOURCE 2 PAY METRO MAPFROM STRATEGIC SOURCING TO PAYMENT
Recognisable contexts, one practitioner pattern. Named environments such as GSK, Merck, Elanco and Bayer, including a GSK Vaccines Belgium recognition for strategic sourcing, stakeholder management, cost reduction and value engineering, reflect professional experience, advisory exposure, employment, speaking, board or transformation contexts. Ongoing client relationships stay confidential. Full context on the About page.